WHO’s new global guidance helps clinicians manage dengue, Zika, chikungunya, and yellow fever with protocols for fluids, ...

Patient safety means healthcare sets a particularly high standard for AI integration but the sector is increasingly ...

Panelists discuss how implementing combination immunotherapy in clinical practice faces institutional barriers, including ...

Eli Lilly's biggest growth driver, tirzepatide, will continue facing scrutiny from investors and analysts. The company's oral ...

Healthcare offers diverse career paths beyond traditional clinical roles like doctors and nurses. Opportunities abound in ...

A chorus of honking cars during Thursday’s rush hour on Caton Avenue signaled support for registered nurses at Baltimore’s ...

Eupraxia Pharmaceuticals Inc. ('Eupraxia” or the 'Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company ...

Medpace has historically maintained a conservative balance sheet. At year-end 2024, cash and cash equivalents totaled $669 million. Medpace generated nearly $191 million in cash flow from operating ...

In 2024, Banner Wyoming Medical Center met the majority of its 17 contractual covenants — such as maintaining essential services and adding new technologies. It fell short in four areas.

Novo Nordisk's recent financial results and clinical progress haven't impressed Wall Street. Investors looking to strike while the iron is hot can buy beaten-down stocks that appear to have excellent ...

Professor James Wolffsohn, chief scientific officer at the International Myopia Institute, gave OT an insight into the latest ...